Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non‐small cell lung cancer from proteomic profiling of circulating extracellular vesicles

BACKGROUND: Risk factors for predicting pneumonitis during durvalumab consolidation after chemoradiotherapy (CRT) in locally advanced non‐small cell lung cancer (LA‐NSCLC) are still lacking. Extracellular vesicles (EVs) play a crucial role in intercellular communication and are potential diagnostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Torasawa, Masahiro, Horinouchi, Hidehito, Yagishita, Shigehiro, Utsumi, Hirofumi, Okuda, Keitaro, Takekoshi, Daisuke, Ito, Saburo, Wakui, Hiroshi, Murata, Saori, Kaku, Sawako, Okuma, Kae, Matsumoto, Yuji, Shinno, Yuki, Okuma, Yusuke, Yoshida, Tatsuya, Goto, Yasushi, Yamamoto, Noboru, Araya, Jun, Ohe, Yuichiro, Fujita, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569905/
https://www.ncbi.nlm.nih.gov/pubmed/37614219
http://dx.doi.org/10.1111/1759-7714.15077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569905/
https://www.ncbi.nlm.nih.gov/pubmed/37614219
http://dx.doi.org/10.1111/1759-7714.15077

Ejemplares similares